Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.gov public full text Public Domain

ErbB2 Positive Metastatic Breast Cancer

China Medical University Hospital · 2012
ClinicalTrials.gov · Datasets · License: Public Domain · 2012
Open Source ↗
metastatic-breast-cancer
Objectives: Phase I part * Primary Objective: To determine the recommended dose of the combination of lapatinib with Lipo-Dox as first line chemotherapy in patients with ErbB2 positive metastatic breast cancer. * Secondary Objectives:To define the safety profile; To observe the response rate and progression free survival Phase II part * Primary Objective :To determined the objective response rate of the combination of lapatinib with Lipo-Dox as first line chemotherapy in patients with ErbB2 positive metastatic breast cancer. * Secondary Objectives:To define the safety profile; To determined the progression free survival
Conceptio Open Archive

Analyze & explore related research in Conceptio

Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.

This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1453525
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive